Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies
Open Access

Protective Effects of Gamma-mangostin on Hydrogen Peroxideinduced Cytotoxicity in Human Retinal Pigment Epithelial Cells

PEI-SHIN HU, NING-YI HSIA, WEI-CHING CHIEN, MEI-CHIN MONG, TE-CHUN HSIA, HENG-MING CHANG, YUN-CHI WANG, WEN-SHIN CHANG, DA-TIAN BAU and CHIA-WEN TSAI
In Vivo July 2022, 36 (4) 1676-1683; DOI: https://doi.org/10.21873/invivo.12879
PEI-SHIN HU
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
2Department of Ophthalmology, Changhua Christian Hospital, Changhua, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NING-YI HSIA
3Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
4Department of Ophthalmology, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEI-CHING CHIEN
5Cell Therapy Center, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MEI-CHIN MONG
6Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TE-CHUN HSIA
3Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
7The Ph.D. Program for Health Science and Industry, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HENG-MING CHANG
8Department of Dentistry, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUN-CHI WANG
3Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEN-SHIN CHANG
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DA-TIAN BAU
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
9Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: artbau2{at}gmail.com
CHIA-WEN TSAI
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wenwen816{at}gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The role of epigenetic alterations in the pathogenesis of retinal degenerative diseases, such as macular degeneration is not well established. This study aimed to evaluate whether treatments with gamma-mangostin can rescue the hydrogen peroxide (H2O2)-induced cytotoxicity in human retinal pigment epithelial (ARPE-19) cells. Materials and Methods: ARPE-19 cells were treated with H2O2 alone or with gamma-mangostin plus H2O2 to investigate changes relating to cell viability, appearance of sub-G1 cells, antioxidant enzymes, and apoptotic-related proteins. Results: The data showed that under H2O2 treatment of 400 μM, there was a significant decrease in cell viability and enhanced apoptosis, together with an increased expression of Bax, Bad, cleaved-caspase-3, -8, and -9 at the protein level. On the contrary, the protein expression levels of Bcl2 and Bcl-xl were decreased. Gamma-mangostin pre-treatments (2-16 μM) could effectively prevent all alterations. Conclusion: Gamma-mangostin may conduct its eye-protective effects against H2O2-induced oxidative damage via anti- apoptotic and antioxidant mechanisms in ARPE-19 cells.

  • Apoptosis
  • ARPE-19 cells
  • cell viability
  • gamma-mangostin
  • oxidative damage

Across the retinal degenerative diseases, there are two typical pathological features, the chronic oxidative and inflammatory status. Among these retinal degenerative diseases, the age-related macular degeneration (AMD) is the most common cause of blindness among elderly citizens (1). Clinically, AMD will lead to progressive neurosensory macular destruction, which may cover the areas of retinal pigment epithelium (RPE), Bruch’s membrane, and choroid (2). AMD is cut into two stages: the early stage of AMD is characterized by the aberrant pigmentation of the RPE and the accumulation of extracellular deposits of lipid, cellular debris, and proteins (i.e., drusen), while the late (advanced) stage may manifest as non-exudative or exudative AMD (3, 4). In literature, AMD is one of the most investigated multifactorial eye diseases, and there have been many factors involved in the chronic oxidative and inflammatory status of the micro-environment, which may include sociodemographic (age and race) (5), environmental (cigarette smoking, light exposure, and nutrient intake) (6-10), and genetic risk factors (11-14). All of these factors are involved in the oxidative stress and inflammation of AMD (15).

To mimic the oxidative stress and damage, treatment with hydrogen peroxide (H2O2) is one of the most commonly used models both in vitro and in vivo (16, 17). However, the effect of H2O2 is very acute, occurs randomly, is dosedependent and has multi-output effects, including cell proliferation, migration, survival, differentiation (18, 19) and cell death (20, 21). There have been few studies investigating the influence of H2O2 on cell proliferation and apoptosis, and the alterations of antioxidant enzymes, including glutathione peroxidase, superoxide dismutase and catalase (22, 23). However, the results remain inconclusive.

Mangostins belong to natural xanthonoid compounds, which can be isolated from multiple fragments of the mangosteen trees (Garcinia mangostana). Structurally, mangostins all have a core of xanthone. In the literature, mangostins have been reported to have several characters. In addition to anti-bacterial, anticancer and anti-inflammatory capacities, the antioxidant activities attract the most attention (24). In mice and rats, alpha-mangostin has been found to have a central nervous system depressing capacity, although the mechanisms are not clear and there is a lack of clinical investigation (25). To prevent potential adverse effects, we focused on examining the efficacy of gamma-mangostin (Man), which is a member of the class of xanthones and is isolated from the stems of Cratoxylum cochinchinense. Man has been reported to exhibit anticancer activity (26). Compared with alpha- and beta-mangostin, it is less frequently studied. As far as we know, the eye-protecting effects of Man and its mechanisms have not been previously studied.

Materials and Methods

Reagents. Dulbecco’s Modified Eagle’s Medium (DMEM)/F12, penicillin/streptomycin, and certified fetal bovine serum were purchased from Invitrogen (Carlsbad, CA, USA). 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma–Aldrich, Inc (St. Louis, MO, USA). Primary antibodies including anti-Bax (Cat. sc-7480), anti-Bad (Cat. sc- 8044), anti-Bcl2 (Cat. sc-7382), anti-Bcl-xl (Cat. sc-8392), antiuncleaved caspase-3 (Cat. sc-7272), anti-uncleaved caspase-8 (Cat. sc-56070), anti-uncleaved caspase-9 (Cat. sc-56076), anti-cleaved caspase-3 (Cat. sc-56052), anti-cleaved caspase-8 (Cat. sc-81657), anti-cleaved caspase-9 (Cat. sc-56073), anti-β-actin (Cat. sc-47778), and horseradish peroxidase–conjugated secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

Cell culture conditions. Human retinal pigment epithelium (ARPE- 19) cells were purchased from ATCC and routinely maintained in DMEM/F-12 medium, supplemented with 10% fetal bovine serum, 100 U/ml penicillin plus 100 μg/ml streptomycin in a steady 37°C incubator under a humidified 5% CO2 supplement. These cells were passaged every 2 or 3 days and disposed after 15 passages.

MTT assay. Cell viability was evaluated using MTT assay as previously described (27-29). First, to establish the H2O2-induced oxidative stress system, ARPE-19 cells (2×105 cells/well) were treated with 0, 100, 200, 400 and 800 μM of H2O2 for 24 h, and then investigated with MTT assay. To examine the influence of Man on the cell viability of ARPE-19 cells, cells was exposed to 0, 2, 4, 8 and 16 μM of for 24 h. To examine the effects of Man against H2O2-induced cytotoxicity, cultured ARPE-19 cells were pre-treated with indicated concentrations of Man for 24 h, followed by a 24-h exposure of H2O2. After any designed experiments, 10 μl of MTT solution (5 mg/ml) was added to each well and the cells were incubated at 37°C in the dark for another 4 h. The medium was then aspirated and 100 μl of DMSO was added and kept for exactly 10 min. Finally, the absorption was evaluated using a Multiskan MS ELISA reader (Labsystems, Helsinki, Finland).

Flow cytometry analysis for cell apoptosis. Cell apoptosis was examined by Annexin V-FITC/PI methodology. ARPE-19 cells were grown in a six-well plate at a density of 2×105 cells/well and treated with or without Man for 24 h, before treatment with H2O2 for 24 h. Then, the cells in all designed groups were washed twice with icecold PBS, resuspended in 300 μl of binding buffer, and stained with 10 μl of Annexin V-FITC plus 10 μl of PI in the dark for 20 min. After that, the stained cells were analyzed using the FACS Calibur instrument (BD Biosciences, San Jose, CA, USA). Morphological changes were photographed randomly as shown in Figure 1A-F.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

The effects of H2O2 and Man on ARPE-19 cell viability. (A) ARPE-19 cells are observed under a microscope after 24 h treatment with 16 μM of Man (B), 0 (A), 100 (C), 200 (D), 400 (E), and 800 μM of H2O2 (F). (G) The quantification results of 0~16 μM Man treatment for 24 h in ARPE-19 cells. Data are presented as mean±SD of at least three experiments. (H) The quantification results of 0~800 μM H2O2 treatment for 24 h in ARPE-19 cells. Data are presented as mean±SD of at least three experiments. *Statistically significant (p<0.05) compared with the untreated group. (I) Pretreatments of 0~16 μM Man for 24 h to ARPE-19 cells before being challenged by 400 μM H2O2 for 24 h. Data are presented as mean±SD of at least three experiments. *Statistically significant (p<0.05) compared with the untreated group. #Statistically significant (p<0.05) compared with the 400 μM H2O2 alone group.

Antioxidant enzyme measurements. Following treatment, the ARPE- 19 cells were collected and three common antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-PX), were measured. Generally, SOD (Cat. 706002), CAT (Cat. 707002) and GSH-PX (Cat. 703002) activity were detected using commercially available assay kits (Cayman Chemical Company, Milpitas, CA, USA), following the manufacturers’ instructions.

Glutathione measurement. Following treatment, the ARPE-19 cells were harvested, and glutathione were measured using a commercially available assay kit from Sigma–Aldrich, Inc. All the procedures were carried out following the manufacturer’s instructions.

Western blot analysis. Briefly, ARPE-19 cells were pre-treated with Man for 24 h and then challenged with H2O2 for 24 h. Cells were then lysed, and equal amount of cell lysates were separated on a 12% sodium dodecyl sulfate/polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. The separated bands were then subjected to a panel of primary antibodies including anti-Bax, anti-Bad, anti-Bcl2, anti-Bcl-xl, anti-uncleaved caspase-3, antiuncleaved caspase-8, anti-uncleaved caspase-9, anti-cleaved caspase-3, anti-cleaved caspase-8, anti-cleaved caspase-9 and anti- β-actin, followed by incubation with the appropriate horseradish peroxidase-conjugated secondary antibodies. The western blotting process was performed as described previously (28, 29), and every experiment was conducted at least thrice.

Statistical analysis. All statistical comparisons were carried out using one-way ANOVA followed by Tukey’s post-hoc comparison, with p-Value less than 0.05 to be considered statistically significant. Each value is presented as mean±standard deviation (S.D.).

Results

Man protected ARPE-19 cells against H2O2-induced loss of cell viability. To establish an H2O2-induced ARPE-19 cytotoxicity model, the cells were challenged with 0, 100, 200, 400 and 800 μM of H2O2 for 24 h. As shown in Figure 1H, 100, 200, 400 and 800 μM of H2O2, treatments caused 11.6%, 33%, 60.7% and 95.7% loss of cell viability, respectively (Figure 1H). At the same time, the treatments of 2, 4, 8 and 16 μM of Man did not cause a significant loss of cell viability (Figure 1G). Simultaneously, ARPE-19 cells treated with 100, 200, 400, 800 μM of H2O2’ together with those treated with 16 μM of Man, were observed directly under the microscope. Consistently, H2O2 induced a loss of cell viability dose-dependently, while 16 μM of Man did not cause any obvious alteration in cell integrity or loss of viability (Figure 1A-F). Interestingly, the pre-treatment of Man before H2O2 challenge can prevent the consequent damage and loss of cell viability in a dose-dependent manner (Figure 1I).

Man protected ARPE-19 cells against H2O2-induced apoptosis. To examine H2O2-induced ARPE-19 apoptosis, the cells were challenged with 0, 100, 200, 400 and 800 μM of H2O2 for 24 h. As shown in Figure 2A, 100, 200, 400 and 800 μM of H2O2 treatments induced 16.7%, 22.7%, 39.3, 75.7% of ARPE-19 cells to undergo apoptosis, respectively. The treatments of 2, 4, 8 and 16 μM of Man did not induce any significant apoptosis of ARPE-19 cells (data not shown). Meanwhile, 2, 4, 8 and 16 μM of Man pre-treatments could reduce the percentages of apoptotic cells induced by 400 μM of H2O2 dose-dependently (Figure 2B).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

The effects of H2O2 and Man on ARPE-19 cell apoptosis. (A) The effects of 24-h treatment of 0~800 μM H2O2 on ARPE-19 cells. Apoptotic cells were detected by flow cytometry with sub-G1. Data are presented as mean±SD for at least 3 experiments. *statistically significant (p<0.05) compared with the untreated group. (B) Pre-treatments of 0~16 μM Man for 24 h to ARPE-19 cells before being challenged by 400 μM H2O2 for 24 h. Data are presented as mean±SD for at least 3 experiments. *Statistically significant (p<0.05) compared with the untreated group. #Statistically significant (p<0.05) compared with the 400 μM H2O2 alone group.

Man rescued H2O2-induced loss of antioxidant capacity in ARPE-19 cells. To explore the influence of H2O2 on antioxidant capacity in ARPE-19 cells, the cells were challenged with 400 μM of H2O2 for 24 h, and the status of 3 antioxidant enzymes, SOD, CAT and GSH-Px, together with GSH were measured. As shown in the figures, 400 μM of H2O2 treatment could decrease the activity of SOD, CAT and GSH-Px, in addition to the level of GSH (Figure 3A-D). At the same time, 16 μM of Man could enhance the activity of SOD and GSH-Px (Figure 3A and C), but not those of CAT or GSH (Figure 3B and D). Although to different degrees, 2, 4, 8 and 16 μM of Man were capable of rescuing the H2O2-induced loss of antioxidant status (Figure 3A-D).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

The effects of H2O2 and Man on antioxidant status of ARPE-19 cells. Pre-treatments of 0~16 μM Man for 24 h to ARPE-19 cells before challenged by 400 μM H2O2for 24 h. Then the activity of SOD (A), CAT (B), GSH-Px (C), and the relative amounts of GSH (D) were measured. Data are presented as mean±SD of at least three experiments. *Statistically significant (p<0.05) compared with the untreated group. *Statistically significant (p<0.05) compared with the 400 μM H2O2 alone group.

Man reversed H2O2-induced alterations in apoptotic-related proteins of ARPE-19 cells. To confirm the influence of H2O2, and to check the reverse effects of Man on H2O2-induced alterations in ARPE-19 cells, the cells were pre-treated with various doses of Man, then challenged with 400 μM of H2O2 for 24 h, and the expression levels of apoptotic-related proteins were measured, including Bax, Bad, Bcl2, Bcl-xl, together with uncleaved and cleaved forms of casepase-3, - 8, and -9. As shown in Figure 4, 400 μM of H2O2 treatment could enhance the levels of Bax, Bad (Figure 4A), cleaved caspase-3, -8 and -9 (Figure 4B). On the contrary, the levels of Bcl2 and Bcl-xl were decreased by the H2O2 challenge (Figure 4A), while the uncleaved form of caspase-3, -8 and -9 were unaltered. The pre-treatments of 4 and 16 μM Man could reverse the influences of H2O2 on Bax, Bad, Bcl2, Bcl-xl, cleaved casepase-3, -8, and -9 (Figure 4A and B).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

The effects of H2O2 and Man on the expression levels of apoptotic-relatedproteins in ARPE-19 cells. (A) The effects of H2O2 and Man on the expression levels of Bax, Bad, Bcl2 and Bcl-xL in ARPE-19 cells, accessed by Western blotting assay. Pre-treatments of 0~16 μM Man for 24 h to ARPE-19 cells before challenged by 400 μM H2O2 for 24 h. β-actin served as internal standard for loading control. (B) The effects of H2O2 and Man on the expression levels of uncleaved and cleaved forms of caspase-3, -8 and -9 in ARPE-19 cells, accessed by Western blotting assay. Pre-treatments of 0~16 μM Man for 24 h to ARPE-19 cells before being challenged by 400 μM H2O2 for 24 h. β-actin served as internal standard for loading control. Experiments were repeated at least thrice.

Discussion

Although the precise pathogenesis of age-related macular degeneration (AMD) remains largely unclear, oxidative damage-induced loss of function in retinal pigment epithelium cells is thought to be the pathological cause in the initial stage of the AMD progress (30, 31). In addition, several lines of evidence have shown that reactive oxygen species-induced damage to retinal pigment epithelium cells are closely related to AMD (32, 33). Thus, in order to reveal the etiology of AMD and provide eye-protective strategy, the models of reactive oxygen species-induced damage to retinal pigment epithelium cells should be established for drug discovery and screening. To fulfill that, we have set up an H2O2-damage cell model in ARPE-19 cells.

Mangostins have been found to have antioxidant capacity (34, 35). In recent decades, alpha-mangostin has attracted most of the attention, which has been focused on its apoptosisinducing capacity in colorectal cancer (36, 37). Following colorectal cell lines, a panel of cancer cell lines including breast and skin cancer cell lines, were also tested for validating its anti-cancer ability (38-42). In 2016, Fang and colleagues first found that in ARPE-19 cells, alpha-mangostin has protective effects on the cells in respect to oxidative-induced apoptosis (43). However, they did not investigate the effects of other mangostins (beta- and gamma-forms) and the effects of them on oxidative damage and apoptosis.

It is believed that reactive oxygen species-induced apoptotic cascades may play a critical role in AMD (44). From the same viewpoint, drugs which may improve the antioxidant capacity and do good to the mitochondrial integrity may have beneficial effects in fighting against AMD (45). Thus, we focused on the Bcl-2 family proteins which have anti-apoptotic (Bcl2 and Bcl-xl) and pro-apoptotic (Bax and Bad) properties, respectively (Figure 4A). In addition, the activation of caspase cascade is also critical; we have investigated the alterations about caspase-8, -9, and -3 (Figure 4B). Furthermore, we have checked the overall antioxidant status via measuring the alterations of SOD, CAT, GSH-Px, and GSH (Figure 3). We not only investigated the alterations after H2O2 treatment, but also the differences between with and without the pre-treatment of Man.

The highlights of the current study include that Man is effective in conducting its antioxidant capacity for the first time in ARPE-19 cells (Figure 1 and Figure 2). In addition, Man is capable of reversing H2O2-induced loss of antioxidant capacity of SOD, CAT, and GSH-Px (Figure 3). Furthermore, Man is also capable of reversing H2O2-induced alterations of Bax, Bad, Bcl2, Bcl-xl, cleaved casepase-3, -8, and -9 (Figure 4). The most important fact is that Man can be a strong antioxidant as alpha-mangostin was reported to protect ARPE-19 cells from oxidative stress (46). In our unpublished data, we have found that Man is more effective than alpha-mangostin in ARPE-19 cells (data not shown). Safety is another critical concern in clinical drugs. In the data of Chuang, 20 μM of alpha-mangostin caused a loss of cell viability by about 40% (46), while Man caused almost no loss of cell viability (Figure 1G) in the same ARPE-19 cell line. The oxidative stressor in our study is H2O2, while Chuang et al. used NaIO3 (46).

In conclusion, the study has a solid and systematic set of results showing that Man effectively protected ARPE-19 cells against H2O2-induced stress via re-activating anti-apoptotic and antioxidant mechanisms. These findings polish the potential of Man as a novel drug for AMD and other diseases. Further investigations, such as those in mice or rat models, are needed for a better understanding of the underlying mechanisms and possible clinical practice.

Acknowledgements

The study has been supported by Chang Bing Show Chwan Memorial Hospital (BRD-109011), China Medical University Hospital (DMR-110-117), Asia University plus China Medical University (CMU110-ASIA-05) and Changhua Christian Hospital (109-CCH-IRP-113).

Footnotes

  • Authors’ Contributions

    Hu PS, Hsia NY and Chien WC conceived and designed the experiments. Mong MC, Wang YC and Chang WS performed the experiments. Hsia TC Chang HM and Tsai CW analyzed the data. Hu PS and Hsia NY contributed with reagents, materials and analysis tools. Tsai CW and Bau DT wrote and revised the article.

  • Conflicts of Interest

    The Authors declare no conflicts of interest in regard to this study.

  • Received April 2, 2022.
  • Revision received April 26, 2022.
  • Accepted April 27, 2022.
  • Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

References

  1. ↵
    1. Rudnicka AR,
    2. Jarrar Z,
    3. Wormald R,
    4. Cook DG,
    5. Fletcher A and
    6. Owen CG
    : Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119(3): 571-580, 2012. PMID: 22176800. DOI: 10.1016/j.ophtha.2011.09.027
    OpenUrlCrossRefPubMed
  2. ↵
    1. Jager RD,
    2. Mieler WF and
    3. Miller JW
    : Age-related macular degeneration. N Engl J Med 358(24): 2606-2617, 2008. PMID: 18550876. DOI: 10.1056/NEJMra0801537
    OpenUrlCrossRefPubMed
  3. ↵
    1. Ding X,
    2. Patel M and
    3. Chan CC
    : Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28(1): 1-18, 2009. PMID: 19026761. DOI: 10.1016/j.preteyeres.2008.10.001
    OpenUrlCrossRefPubMed
  4. ↵
    1. Ferris FL,
    2. Davis MD,
    3. Clemons TE,
    4. Lee LY,
    5. Chew EY,
    6. Lindblad AS,
    7. Milton RC,
    8. Bressler SB,
    9. Klein R
    and Age-Related Eye Disease Study (AREDS) Research Group: A simplified severity scale for age-related macular degeneration: AREDS Report 18. Arch Ophthalmol 123(11): 1570-1574, 2005. PMID: 16286620. DOI: 10.1001/archopht.123.11.1570
    OpenUrlCrossRefPubMed
  5. ↵
    1. Colijn JM,
    2. Buitendijk GHS,
    3. Prokofyeva E,
    4. Alves D,
    5. Cachulo ML,
    6. Khawaja AP,
    7. Cougnard-Gregoire A,
    8. Merle BMJ,
    9. Korb C,
    10. Erke MG,
    11. Bron A,
    12. Anastasopoulos E,
    13. Meester-Smoor MA,
    14. Segato T,
    15. Piermarocchi S,
    16. de Jong PTVM,
    17. Vingerling JR,
    18. Topouzis F,
    19. Creuzot-Garcher C,
    20. Bertelsen G,
    21. Pfeiffer N,
    22. Fletcher AE,
    23. Foster PJ,
    24. Silva R,
    25. Korobelnik JF,
    26. Delcourt C,
    27. Klaver CCW
    , EYE-RISK consortium and European Eye Epidemiology (E3) consortium: Prevalence of age-related macular degeneration in Europe: The past and the future. Ophthalmology 124(12): 1753-1763, 2017. PMID: 28712657. DOI: 10.1016/j.ophtha.2017.05.035
    OpenUrlCrossRefPubMed
  6. ↵
    1. Tomany SC,
    2. Cruickshanks KJ,
    3. Klein R,
    4. Klein BE and
    5. Knudtson MD
    : Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 122(5): 750-757, 2004. PMID: 15136324. DOI: 10.1001/ archopht.122.5.750
    OpenUrlCrossRefPubMed
    1. Thornton J,
    2. Edwards R,
    3. Mitchell P,
    4. Harrison RA,
    5. Buchan I and
    6. Kelly SP
    : Smoking and age-related macular degeneration: a review of association. Eye (Lond) 19(9): 935-944, 2005. PMID: 16151432. DOI: 10.1038/sj.eye.6701978
    OpenUrlCrossRefPubMed
    1. Seddon JM,
    2. Ajani UA,
    3. Sperduto RD,
    4. Hiller R,
    5. Blair N,
    6. Burton TC,
    7. Farber MD,
    8. Gragoudas ES,
    9. Haller J and
    10. Miller DT
    : Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 272(18): 1413-1420, 1994. PMID: 7933422.
    OpenUrlCrossRefPubMed
    1. Tomany SC,
    2. Klein R,
    3. Klein BE
    and Beaver Dam Eye Study: The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110(8): 1526-1533, 2003. PMID: 12917167. DOI: 10.1016/s0161-6420(03)00539-6
    OpenUrlCrossRefPubMed
  7. ↵
    1. Seddon JM,
    2. Rosner B,
    3. Sperduto RD,
    4. Yannuzzi L,
    5. Haller JA,
    6. Blair NP and
    7. Willett W
    : Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 119(8): 1191-1199, 2001. PMID: 11483088. DOI: 10.1001/archopht.119.8.1191
    OpenUrlCrossRefPubMed
  8. ↵
    1. Fritsche LG,
    2. Chen W,
    3. Schu M,
    4. Yaspan BL,
    5. Yu Y,
    6. Thorleifsson G,
    7. Zack DJ,
    8. Arakawa S,
    9. Cipriani V,
    10. Ripke S,
    11. Igo RP Jr.,
    12. Buitendijk GH,
    13. Sim X,
    14. Weeks DE,
    15. Guymer RH,
    16. Merriam JE,
    17. Francis PJ,
    18. Hannum G,
    19. Agarwal A,
    20. Armbrecht AM,
    21. Audo I,
    22. Aung T,
    23. Barile GR,
    24. Benchaboune M,
    25. Bird AC,
    26. Bishop PN,
    27. Branham KE,
    28. Brooks M,
    29. Brucker AJ,
    30. Cade WH,
    31. Cain MS,
    32. Campochiaro PA,
    33. Chan CC,
    34. Cheng CY,
    35. Chew EY,
    36. Chin KA,
    37. Chowers I,
    38. Clayton DG,
    39. Cojocaru R,
    40. Conley YP,
    41. Cornes BK,
    42. Daly MJ,
    43. Dhillon B,
    44. Edwards AO,
    45. Evangelou E,
    46. Fagerness J,
    47. Ferreyra HA,
    48. Friedman JS,
    49. Geirsdottir A,
    50. George RJ,
    51. Gieger C,
    52. Gupta N,
    53. Hagstrom SA,
    54. Harding SP,
    55. Haritoglou C,
    56. Heckenlively JR,
    57. Holz FG,
    58. Hughes G,
    59. Ioannidis JP,
    60. Ishibashi T,
    61. Joseph P,
    62. Jun G,
    63. Kamatani Y,
    64. Katsanis N, N
    65. Keilhauer C,
    66. Khan JC,
    67. Kim IK,
    68. Kiyohara Y,
    69. Klein BE,
    70. Klein R,
    71. Kovach JL,
    72. Kozak I,
    73. Lee CJ,
    74. Lee KE,
    75. Lichtner P,
    76. Lotery AJ,
    77. Meitinger T,
    78. Mitchell P,
    79. Mohand-Saïd S,
    80. Moore AT,
    81. Morgan DJ,
    82. Morrison MA,
    83. Myers CE,
    84. Naj AC,
    85. Nakamura Y,
    86. Okada Y,
    87. Orlin A,
    88. Ortube MC,
    89. Othman MI,
    90. Pappas C,
    91. Park KH,
    92. Pauer GJ,
    93. Peachey NS,
    94. Poch O,
    95. Priya RR,
    96. Reynolds R,
    97. Richardson AJ,
    98. Ripp R,
    99. Rudolph G,
    100. Ryu E,
    101. Sahel JA,
    102. Schaumberg DA,
    103. Scholl HP,
    104. Schwartz SG,
    105. Scott WK,
    106. Shahid H,
    107. Sigurdsson H,
    108. Silvestri G,
    109. Sivakumaran TA,
    110. Smith RT,
    111. Sobrin L,
    112. Souied EH,
    113. Stambolian DE,
    114. Stefansson H,
    115. Sturgill-Short GM,
    116. Takahashi A,
    117. Tosakulwong N,
    118. Truitt BJ,
    119. Tsironi EE,
    120. Uitterlinden AG,
    121. van Duijn CM,
    122. Vijaya L,
    123. Vingerling JR,
    124. Vithana EN,
    125. Webster AR,
    126. Wichmann HE,
    127. Winkler TW,
    128. Wong TY,
    129. Wright AF,
    130. Zelenika D,
    131. Zhang M,
    132. Zhao L,
    133. Zhang K,
    134. Klein ML,
    135. Hageman GS,
    136. Lathrop GM,
    137. Stefansson K,
    138. Allikmets R,
    139. Baird PN,
    140. Gorin MB,
    141. Wang JJ,
    142. Klaver CC,
    143. Seddon JM,
    144. Pericak-Vance MA,
    145. Iyengar SK,
    146. Yates JR,
    147. Swaroop A,
    148. Weber BH,
    149. Kubo M,
    150. Deangelis MM,
    151. Léveillard T,
    152. Thorsteinsdottir U,
    153. Haines JL,
    154. Farrer LA,
    155. Heid IM,
    156. Abecasis GR
    and AMD Gene Consortium: Seven new loci associated with age-related macular degeneration. Nat Genet 45(4): 433-9, 439e1-2, 2013. PMID: 23455636. DOI: 10.1038/ng.2578
    OpenUrlCrossRefPubMed
    1. Fritsche LG,
    2. Igl W,
    3. Bailey JN,
    4. Grassmann F,
    5. Sengupta S,
    6. Bragg-Gresham JL,
    7. Burdon KP,
    8. Hebbring SJ,
    9. Wen C,
    10. Gorski M,
    11. Kim IK,
    12. Cho D,
    13. Zack D,
    14. Souied E,
    15. Scholl HP,
    16. Bala E,
    17. Lee KE,
    18. Hunter DJ,
    19. Sardell RJ,
    20. Mitchell P,
    21. Merriam JE,
    22. Cipriani V,
    23. Hoffman JD,
    24. Schick T,
    25. Lechanteur YT,
    26. Guymer RH,
    27. Johnson MP,
    28. Jiang Y,
    29. Stanton CM,
    30. Buitendijk GH,
    31. Zhan X,
    32. Kwong AM,
    33. Boleda A,
    34. Brooks M,
    35. Gieser L,
    36. Ratnapriya R,
    37. Branham KE,
    38. Foerster JR,
    39. Heckenlively JR,
    40. Othman MI,
    41. Vote BJ,
    42. Liang HH,
    43. Souzeau E,
    44. McAllister IL,
    45. Isaacs T,
    46. Hall J,
    47. Lake S,
    48. Mackey DA,
    49. Constable IJ,
    50. Craig JE,
    51. Kitchner TE,
    52. Yang Z,
    53. Su Z,
    54. Luo H,
    55. Chen D,
    56. Ouyang H,
    57. Flagg K,
    58. Lin D,
    59. Mao G,
    60. Ferreyra H,
    61. Stark K,
    62. von Strachwitz CN,
    63. Wolf A,
    64. Brandl C,
    65. Rudolph G,
    66. Olden M,
    67. Morrison MA,
    68. Morgan DJ,
    69. Schu M,
    70. Ahn J,
    71. Silvestri G,
    72. Tsironi EE,
    73. Park KH,
    74. Farrer LA,
    75. Orlin A,
    76. Brucker A,
    77. Li M,
    78. Curcio CA,
    79. Mohand-Saïd S,
    80. Sahel JA,
    81. Audo I,
    82. Benchaboune M,
    83. Cree AJ,
    84. Rennie CA,
    85. Goverdhan SV,
    86. Grunin M,
    87. Hagbi-Levi S,
    88. Campochiaro P,
    89. Katsanis N,
    90. Holz FG,
    91. Blond F,
    92. Blanché H,
    93. Deleuze JF,
    94. Igo RP Jr.,
    95. Truitt B,
    96. Peachey NS,
    97. Meuer SM,
    98. Myers CE,
    99. Moore EL,
    100. Klein R,
    101. Hauser MA,
    102. Postel EA,
    103. Courtenay MD,
    104. Schwartz SG,
    105. Kovach JL,
    106. Scott WK,
    107. Liew G,
    108. Tan AG,
    109. Gopinath B,
    110. Merriam JC,
    111. Smith RT,
    112. Khan JC,
    113. Shahid H,
    114. Moore AT,
    115. McGrath JA,
    116. Laux R,
    117. Brantley MA Jr.,
    118. Agarwal A,
    119. Ersoy L,
    120. Caramoy A,
    121. Langmann T,
    122. Saksens NT,
    123. de Jong EK,
    124. Hoyng CB,
    125. Cain MS,
    126. Richardson AJ,
    127. Martin TM,
    128. Blangero J,
    129. Weeks DE,
    130. Dhillon B,
    131. van Duijn CM,
    132. Doheny KF,
    133. Romm J,
    134. Klaver CC,
    135. Hayward C,
    136. Gorin MB,
    137. Klein ML,
    138. Baird PN,
    139. den Hollander AI,
    140. Fauser S,
    141. Yates JR,
    142. Allikmets R,
    143. Wang JJ,
    144. Schaumberg DA,
    145. Klein BE,
    146. Hagstrom SA,
    147. Chowers I,
    148. Lotery AJ,
    149. Léveillard T,
    150. Zhang K,
    151. Brilliant MH,
    152. Hewitt AW,
    153. Swaroop A,
    154. Chew EY,
    155. Pericak-Vance MA,
    156. DeAngelis M,
    157. Stambolian D,
    158. Haines JL,
    159. Iyengar SK,
    160. Weber BH,
    161. Abecasis GR and
    162. Heid IM
    : A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 48(2): 134-143, 2016. PMID: 26691988. DOI: 10.1038/ng.3448
    OpenUrlCrossRefPubMed
    1. Barchitta M and
    2. Maugeri A
    : Association between vascular endothelial growth factor polymorphisms and age-related macular degeneration: an updated meta-analysis. Dis Markers 2016: 8486406, 2016. PMID: 27999450. DOI: 10.1155/2016/8486406
    OpenUrlCrossRefPubMed
  9. ↵
    1. Maugeri A,
    2. Barchitta M and
    3. Agodi A
    : The association between complement factor H rs1061170 polymorphism and age-related macular degeneration: a comprehensive meta-analysis stratified by stage of disease and ethnicity. Acta Ophthalmol 97(1): e8-e21, 2019. PMID: 30280493. DOI: 10.1111/aos.13849
    OpenUrlCrossRefPubMed
  10. ↵
    1. Seddon JM,
    2. George S,
    3. Rosner B and
    4. Klein ML
    : CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 61(3): 157-165, 2006. PMID: 16816528. DOI: 10.1159/000094141
    OpenUrlCrossRefPubMed
  11. ↵
    1. Chang WS,
    2. Tsai CW,
    3. Lin CC,
    4. Lin CH,
    5. Shen WC,
    6. Lin SS and
    7. Bau DT
    : Earthworms repair H2O2-induced oxidative DNA adducts without removing UV-induced pyrimidine dimers. In Vivo 25(6): 977-981, 2011. PMID: 22021692.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Wu S,
    2. Liu X,
    3. Cheng L,
    4. Wang D,
    5. Qin G,
    6. Zhang X,
    7. Zhen Y,
    8. Wang T and
    9. Sun Z
    : Protective mechanism of leucine and isoleucine against H2O2-induced oxidative damage in bovine mammary epithelial cells. Oxid Med Cell Longev 2022: 4013575, 2022. PMID: 35360198. DOI: 10.1155/2022/4013575
    OpenUrlCrossRefPubMed
  13. ↵
    1. Rhee SG,
    2. Bae YS,
    3. Lee SR and
    4. Kwon J
    : Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000(53): pe1, 2000. PMID: 11752613. DOI: 10.1126/stke.2000.53.pe1
    OpenUrlCrossRefPubMed
  14. ↵
    1. Finkel T
    : Signal transduction by reactive oxygen species. J Cell Biol 194(1): 7-15, 2011. PMID: 21746850. DOI: 10.1083/jcb.201102095
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Eno CO,
    2. Zhao G,
    3. Venkatanarayan A,
    4. Wang B,
    5. Flores ER and
    6. Li C
    : Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress. Free Radic Biol Med 65: 26-37, 2013. PMID: 23770082. DOI: 10.1016/j.freeradbiomed.2013.05.051
    OpenUrlCrossRefPubMed
  16. ↵
    1. Kim YN,
    2. Jung HY,
    3. Eum WS,
    4. Kim DW,
    5. Shin MJ,
    6. Ahn EH,
    7. Kim SJ,
    8. Lee CH,
    9. Yong JI,
    10. Ryu EJ,
    11. Park J,
    12. Choi JH,
    13. Hwang IK and
    14. Choi SY
    : Neuroprotective effects of PEP-1-carbonyl reductase 1 against oxidative-stress-induced ischemic neuronal cell damage. Free Radic Biol Med 69: 181-196, 2014. PMID: 24440593. DOI: 10.1016/j.freeradbiomed.2014.01.006
    OpenUrlCrossRefPubMed
  17. ↵
    1. Muangnoi C,
    2. Phumsuay R,
    3. Jongjitphisut N,
    4. Waikasikorn P,
    5. Sangsawat M,
    6. Rashatasakhon P,
    7. Paraoan L and
    8. Rojsitthisak P
    : Protective effects of a lutein ester prodrug, lutein diglutaric acid, against H2O2-induced oxidative stress in human retinal pigment epithelial cells. Int J Mol Sci 22(9): 4722, 2021. PMID: 33946898. DOI: 10.3390/ijms22094722
    OpenUrlCrossRefPubMed
  18. ↵
    1. Ni T,
    2. Yang W and
    3. Xing Y
    : Protective effects of delphinidin against H2O2-induced oxidative injuries in human retinal pigment epithelial cells. Biosci Rep 39(8): BSR20190689, 2019. PMID: 31345961. DOI: 10.1042/BSR20190689
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Jung HA,
    2. Su BN,
    3. Keller WJ,
    4. Mehta RG and
    5. Kinghorn AD
    : Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem 54(6): 2077-2082, 2006. PMID: 16536578. DOI: 10.1021/jf052649z
    OpenUrlCrossRefPubMed
  20. ↵
    1. Obolskiy D,
    2. Pischel I,
    3. Siriwatanametanon N and
    4. Heinrich M
    : Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res 23(8): 1047-1065, 2009. PMID: 19172667. DOI: 10.1002/ptr.2730
    OpenUrlCrossRefPubMed
  21. ↵
    1. Chang HF and
    2. Yang LL
    : Gamma-mangostin, a micronutrient of mangosteen fruit, induces apoptosis in human colon cancer cells. Molecules 17(7): 8010-8021, 2012. PMID: 22759914. DOI: 10.3390/molecules17078010
    OpenUrlCrossRefPubMed
  22. ↵
    1. Lee MR,
    2. Lin C,
    3. Lu CC,
    4. Kuo SC,
    5. Tsao JW,
    6. Juan YN,
    7. Chiu HY,
    8. Lee FY,
    9. Yang JS and
    10. Tsai FJ
    : YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells. Biomedicine (Taipei) 7(2): 12, 2017. PMID: 28612710. DOI: 10.1051/bmdcn/2017070205
    OpenUrlCrossRefPubMed
  23. ↵
    1. Huang TY,
    2. Peng SF,
    3. Huang YP,
    4. Tsai CH,
    5. Tsai FJ,
    6. Huang CY,
    7. Tang CH,
    8. Yang JS,
    9. Hsu YM,
    10. Yin MC,
    11. Huang WW and
    12. Chung JG
    : Combinational treatment of all-trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)-induced apoptosis in liver cancer Hep3B cells. J Food Biochem 44(2): e13122, 2020. PMID: 31837044. DOI: 10.1111/jfbc.13122
    OpenUrlCrossRefPubMed
  24. ↵
    1. Tsai CL,
    2. Tsai CW,
    3. Chang WS,
    4. Lin JC,
    5. Shih LC,
    6. He JL and
    7. Bau DT
    : Protective effects of crocetin on arsenic trioxide-induced oxidative stress in human umbilical vein endothelial cells. In Vivo 35(6): 3157-3163, 2021. PMID: 34697146. DOI: 10.21873/ invivo.12610
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. de Jong PT
    : Age-related macular degeneration. N Engl J Med 355(14): 1474-1485, 2006. PMID: 17021323. DOI: 10.1056/NEJMra062326
    OpenUrlCrossRefPubMed
  26. ↵
    1. Nowak JZ
    : Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58(3): 353-363, 2006. PMID: 1684209.
    OpenUrlPubMed
  27. ↵
    1. Cai J,
    2. Nelson KC,
    3. Wu M,
    4. Sternberg P Jr. and
    5. Jones DP
    : Oxidative damage and protection of the RPE. Prog Retin Eye Res 19(2): 205-221, 2000. PMID: 10674708. DOI: 10.1016/ s1350-9462(99)00009-9
    OpenUrlCrossRefPubMed
  28. ↵
    1. Kozlowski MR
    : RPE cell senescence: a key contributor to age-related macular degeneration. Med Hypotheses 78(4): 505-510, 2012. PMID: 22296808. DOI: 10.1016/j.mehy.2012.01.018
    OpenUrlCrossRefPubMed
  29. ↵
    1. Hafeez BB,
    2. Mustafa A,
    3. Fischer JW,
    4. Singh A,
    5. Zhong W,
    6. Shekhani MO,
    7. Meske L,
    8. Havighurst T,
    9. Kim K and
    10. Verma AK
    : α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model. Antioxid Redox Signal 21(5): 682-699, 2014. PMID: 24295217. DOI: 10.1089/ars.2013.5212
    OpenUrlCrossRefPubMed
  30. ↵
    1. Herrera-Aco DR,
    2. Medina-Campos ON,
    3. Pedraza-Chaverri J,
    4. Sciutto-Conde E,
    5. Rosas-Salgado G and
    6. Fragoso-González G
    : Alpha-mangostin: Anti-inflammatory and antioxidant effects on established collagen-induced arthritis in DBA/1J mice. Food Chem Toxicol 124: 300-315, 2019. PMID: 30557668. DOI: 10.1016/j.fct.2018.12.018
    OpenUrlCrossRefPubMed
  31. ↵
    1. Nakagawa Y,
    2. Iinuma M,
    3. Naoe T,
    4. Nozawa Y and
    5. Akao Y
    : Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg Med Chem 15(16): 5620-5628, 2007. PMID: 17553685. DOI: 10.1016/j.bmc.2007.04.071
    OpenUrlCrossRefPubMed
  32. ↵
    1. Watanapokasin R,
    2. Jarinthanan F,
    3. Nakamura Y,
    4. Sawasjirakij N,
    5. Jaratrungtawee A and
    6. Suksamrarn S
    : Effects of α-mangostin on apoptosis induction of human colon cancer. World J Gastroenterol 17(16): 2086-2095, 2011. PMID: 21547127. DOI: 10.3748/wjg.v17.i16.2086
    OpenUrlCrossRefPubMed
  33. ↵
    1. Wang JJ,
    2. Sanderson BJ and
    3. Zhang W
    : Significant anti-invasive activities of α-mangostin from the mangosteen pericarp on two human skin cancer cell lines. Anticancer Res 32(9): 3805-3816, 2012. PMID: 22993323.
    OpenUrlAbstract/FREE Full Text
    1. Xu Q,
    2. Ma J,
    3. Lei J,
    4. Duan W,
    5. Sheng L,
    6. Chen X,
    7. Hu A,
    8. Wang Z,
    9. Wu Z,
    10. Wu E,
    11. Ma Q and
    12. Li X
    : α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Biomed Res Int 2014: 546353, 2014. PMID: 24812621. DOI: 10.1155/2014/546353
    OpenUrlCrossRefPubMed
    1. Chandra Boinpelly V,
    2. Verma RK,
    3. Srivastav S,
    4. Srivastava RK and
    5. Shankar S
    : α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway. J Cell Mol Med 24(19): 11343-11354, 2020. PMID: 32830433. DOI: 10.1111/jcmm.15731
    OpenUrlCrossRefPubMed
    1. Simon SE,
    2. Lim HS,
    3. Jayakumar FA,
    4. Tan EW and
    5. Tan KO
    : Alpha-Mangostin activates MOAP-1 tumor suppressor and mitochondrial signaling in MCF-7 human breast cancer cells. Evid Based Complement Alternat Med 2022: 7548191, 2022. PMID: 35082905. DOI: 10.1155/2022/7548191
    OpenUrlCrossRefPubMed
  34. ↵
    1. Jo MK,
    2. Moon CM,
    3. Kim EJ,
    4. Kwon JH,
    5. Fei X,
    6. Kim SE,
    7. Jung SA,
    8. Kim M,
    9. Mun YC,
    10. Ahn YH,
    11. Seo SY and
    12. Kim TI
    : Suppressive effect of α-mangostin for cancer stem cells in colorectal cancer via the Notch pathway. BMC Cancer 22(1): 341, 2022. PMID: 35351071. DOI: 10.1186/s12885-022-09414-6
    OpenUrlCrossRefPubMed
  35. ↵
    1. Fang Y,
    2. Su T,
    3. Qiu X,
    4. Mao P,
    5. Xu Y,
    6. Hu Z,
    7. Zhang Y,
    8. Zheng X,
    9. Xie P and
    10. Liu Q
    : Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death. Sci Rep 6: 21018, 2016. PMID: 26888416. DOI: 10.1038/srep21018
    OpenUrlCrossRefPubMed
  36. ↵
    1. Flores R,
    2. Carneiro Â,
    3. Vieira M,
    4. Tenreiro S and
    5. Seabra MC
    : Age-related macular degeneration: Pathophysiology, management, and future perspectives. Ophthalmologica 244(6): 495-511, 2021. PMID: 34130290. DOI: 10.1159/000517520
    OpenUrlCrossRefPubMed
  37. ↵
    1. Feher J,
    2. Kovacs B,
    3. Kovacs I,
    4. Schveoller M,
    5. Papale A and
    6. Balacco Gabrieli C
    : Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica 219(3): 154-166, 2005. PMID: 15947501. DOI: 10.1159/000085248
    OpenUrlCrossRefPubMed
  38. ↵
    1. Chuang CJ,
    2. Wang M,
    3. Yeh JH,
    4. Chen TC,
    5. Tsou SC,
    6. Lee YJ,
    7. Chang YY and
    8. Lin HW
    : The protective effects of α-Mangostin attenuate sodium iodate-induced cytotoxicity and oxidative injury via mediating SIRT-3 inactivation via the PI3K/AKT/PGC-1α pathway. Antioxidants (Basel) 10(12): 1870, 2021. PMID: 34942973. DOI: 10.3390/antiox10121870
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

In Vivo: 36 (4)
In Vivo
Vol. 36, Issue 4
July-August 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Protective Effects of Gamma-mangostin on Hydrogen Peroxideinduced Cytotoxicity in Human Retinal Pigment Epithelial Cells
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Protective Effects of Gamma-mangostin on Hydrogen Peroxideinduced Cytotoxicity in Human Retinal Pigment Epithelial Cells
PEI-SHIN HU, NING-YI HSIA, WEI-CHING CHIEN, MEI-CHIN MONG, TE-CHUN HSIA, HENG-MING CHANG, YUN-CHI WANG, WEN-SHIN CHANG, DA-TIAN BAU, CHIA-WEN TSAI
In Vivo Jul 2022, 36 (4) 1676-1683; DOI: 10.21873/invivo.12879

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Protective Effects of Gamma-mangostin on Hydrogen Peroxideinduced Cytotoxicity in Human Retinal Pigment Epithelial Cells
PEI-SHIN HU, NING-YI HSIA, WEI-CHING CHIEN, MEI-CHIN MONG, TE-CHUN HSIA, HENG-MING CHANG, YUN-CHI WANG, WEN-SHIN CHANG, DA-TIAN BAU, CHIA-WEN TSAI
In Vivo Jul 2022, 36 (4) 1676-1683; DOI: 10.21873/invivo.12879
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Development of a Glymphatic Pathway-based Rat Model for Cancer Metastasis from Brain to Lung
  • Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model
  • Oral Administration of Itraconazole Induces M1 Polarization of Tumor-associated Macrophages in Gynecological Cancer
Show more Experimental Studies

Keywords

  • apoptosis
  • ARPE-19 cells
  • cell viability
  • gamma-mangostin
  • oxidative damage
In Vivo

© 2026 In Vivo

Powered by HighWire